Nimodipine
CAS No. 66085-59-4
Nimodipine( Admon | BAY-e 9736 | Periplum )
Catalog No. M15515 CAS No. 66085-59-4
Nimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 100MG | 29 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 60 | In Stock |
|
| 1G | 83 | In Stock |
|
Biological Information
-
Product NameNimodipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.
-
DescriptionNimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.(In Vitro):Nimodipine (1.5~150 μg/ml; 15 minutes; B16a and W256 cells) results in a dose-dependent inhibition of B16a and W256 tumor-cell-induced platelet aggregation. Nimodipine is also inhibitory in a homologous system.(In Vivo):Nimodipine (0.2 μg/μl, intrathecal administration) prevents subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration.Nimodipine(0.1~80 mg/kg; p.o.) results in a significant dose-dependent inhibition of spontaneous metastasis.
-
In VitroNimodipine (1.5~150 μg/ml; 15 minutes; B16a and W256 cells) results in a dose-dependent inhibition of B16a and W256 tumor-cell-induced platelet aggregation. Nimodipine is also inhibitory in a homologous system.
-
In VivoNimodipine (0.2 μg/μl, intrathecal administration) prevents subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration.Nimodipine(0.1~80 mg/kg; p.o.) results in a significant dose-dependent inhibition of spontaneous metastasis. Animal Model:New Zealand white rabbits Dosage:0.2 μg/μl Administration:Intrathecal administration Result:Prevented subarachnoid hemorrhage-associated cerebral vasospasm by prophylactic continuous intrathecal administration.
-
SynonymsAdmon | BAY-e 9736 | Periplum
-
PathwayEndocrinology/Hormones
-
TargetAhR
-
RecptorAhR| Calcium Channel| Mineralocorticoid Receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number66085-59-4
-
Formula Weight418.44
-
Molecular FormulaC21H26N2O7
-
Purity>98% (HPLC)
-
SolubilityEthanol: 84 mg/mL (200.74 mM); DMSO: 84 mg/mL (200.74 mM)
-
SMILESCC1=C(C(OCCOC)=O)C(C2=CC([N+]([O-])=O)=CC=C2)C(C(OC(C)C)=O)=C(C)N1
-
Chemical Name3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ITE
A endogenous ligand, potent aryl hydrocarbon receptor (AhR) agonist in vitro; activates the murine AhR in vivo.
-
Indoxyl sulfate pota...
Indoxyl sulfate (potassium salt) is an agonist for the human aryl hydrocarbon receptor (AHR). The aryl hydrocarbon receptor (AhR) has recently emerged as a pathophysiological regulator of immune-inflammatory conditions and Indoxyl sulfate has been shown to be a ligand for AhR.
-
(-)-Perillaldehyde
(-)-Perillaldehyde shows antibacterial activity.METHODS AND RESULTS: Citral, trans-cinnamaldehyde, (-)-Perillaldehyde, (-)-citronellal, eugenol and carvacrol were tested for their influence on microbial count in air by vaporizing with an air washer. The highest antibacterial activity was observed when (-)-Perillaldehyde was sprayed.
Cart
sales@molnova.com